Takeda is sharpening its oncology focus amid an R&D revamp. Sun Pharma will acquire Checkpoint Therapeutics and an ...
3d
India aims for Rs 17,000 crore investment in pharma R&D by FY28 through PRIP scheme, focusing on innovation and growth.
Treatments for autoimmune diseases and those in orphan markets are on the up and up, as are drugmakers’ first launches, ...
R&,D outsourcing involves pharmaceutical companies subcontracting parts of their R&,D efforts to third-party service providers. Small or mid-sized pharmaceutical or biotech houses may use ...
The Department of Pharmaceuticals has invited expressions of interest for project funding under the PRIP scheme, aiming to transform India into a global R&D hub in the Pharma MedTech sector.
set up a pharmaceutical business in 1876. He was a pioneer of new methods in the industry, being one of the first to focus on R&D as well as manufacturing. Another military man in the drugs ...
Two years after first announcing the partnership, Boehringer Ingelheim and software firm Veeva Systems have launched ...
Finnish drugmaker Orion Corporation has announced that it is establishing a new research and development (R&D) center in Cambridge, UK, during 2025 to accelerate its global growth strategy and the ...
Our Bureau, New Delhi Monday, March 10, 2025, 17:10 Hrs [IST] The Department of Pharmaceuticals (DoP) has released the Expre ...
Teva Pharmaceutical Industries Limited ( NYSE: TEVA) Barclays 27th Annual Global Healthcare Conference March 11, 2025 8:00 AM ET Good morning, everyone. My name is Balaji Prasad. I'm the Senior ...
Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback